Table 2 Noncompliance rates in patient subgroups
From: Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey
Characteristic | Noncompliance rate, n (%) | P |
|---|---|---|
Sex | Â | 0.903 |
Male | 98/479 (21) | Â |
Female | 107/531 (20) | Â |
History of Smoking | 73/364 (20) | 0.886 |
Family history of cancer | 10/85 (12) | 0.041 |
Residence | Â | <.001 |
Refugee Camp | 146/442 (33) | Â |
House | 59/568 (10) | Â |
Diagnosis | Â | 0.141 |
Breast cancer | 65/303 (22) | Â |
Lung cancer | 24/137 (18) | Â |
CNS cancer | 25/128 (20) | Â |
Head and neck cancer | 25/110 (23) | Â |
GI cancer | 15/101 (15) | Â |
Prostate cancer | 16/69 (23) | Â |
Gyn cancer | 7/64 (11) | Â |
Others | 28/98 (28) | Â |
Stage | Â | 0.192 |
I-II | 46/202 (23) | Â |
III-IV | 128/687 (19) | Â |
Concurrent chemoradiotherapy | 62/264 (24) | 0.134 |
Grade 3–4 acute toxicity | 20/139 (14) | 0.062 |